Matthew P. Young Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew P. Young.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew P. Young. Matthew P. Young is EVP & CFO in Jazz Pharmaceuticals plc ($JAZZ) and SVP & CFO in Jazz Pharmaceuticals plc ($JAZZ) and Director in CytomX Therapeutics, Inc. ($CTMX) and Director in PRA Health Sciences, Inc. ($PRAH).
Latest Insider Trading Transactions of Matthew P. Young
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTMX, JAZZ, PRAH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 7.13 | 20,000 | 142,600 | 20,000 | |
| Jun 17 2020 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 8.35 | 20,000 | 167,000 | 20,000 | |
| May 20 2020 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Grant | A | 0.00 | 1,324 | 0 | 6,877 | 5.6 K to 6.9 K (+23.84 %) |
| Jun 21 2019 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 11.31 | 14,000 | 158,340 | 14,000 | |
| Jun 05 2019 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Grant | A | 0.00 | 1,436 | 0 | 5,553 | 4.1 K to 5.6 K (+34.88 %) |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 135.41 | 1,152 | 155,992 | 36,200 | 37.4 K to 36.2 K (-3.08 %) |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 135.82 | 1,348 | 183,085 | 37,352 | 38.7 K to 37.4 K (-3.48 %) |
| Mar 07 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 135.82 | 1,267 | 172,084 | 38,700 | 40 K to 38.7 K (-3.17 %) |
| Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 140.03 | 29,286 | 4,100,919 | 29,286 | |
| Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 140.03 | 714 | 99,981 | 714 | |
| Mar 04 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 12,000 | 0 | 39,967 | 28 K to 40 K (+42.91 %) |
| Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 137.91 | 884 | 121,912 | 27,967 | 28.9 K to 28 K (-3.06 %) |
| Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 127.76 | 1,034 | 132,104 | 28,851 | 29.9 K to 28.9 K (-3.46 %) |
| Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 125.93 | 1,032 | 129,960 | 29,885 | 30.9 K to 29.9 K (-3.34 %) |
| Feb 27 2019 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 126.25 | 1,218 | 153,773 | 30,917 | 32.1 K to 30.9 K (-3.79 %) |
| Nov 27 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 150.00 | 700 | 105,000 | 32,068 | 32.8 K to 32.1 K (-2.14 %) |
| Oct 17 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 158.08 | 700 | 110,658 | 32,768 | 33.5 K to 32.8 K (-2.09 %) |
| Sep 19 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 162.70 | 700 | 113,890 | 33,468 | 34.2 K to 33.5 K (-2.05 %) |
| Aug 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 176.05 | 700 | 123,235 | 34,168 | 34.9 K to 34.2 K (-2.01 %) |
| Jul 18 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 176.06 | 700 | 123,242 | 34,868 | 35.6 K to 34.9 K (-1.97 %) |
| Jun 25 2018 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Grant | A | 0.00 | 1,307 | 0 | 4,117 | 2.8 K to 4.1 K (+46.51 %) |
| Jun 19 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 176.99 | 700 | 123,893 | 35,568 | 36.3 K to 35.6 K (-1.93 %) |
| Jun 15 2018 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 25.25 | 14,000 | 353,500 | 14,000 | |
| Jun 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | M | 58.72 | 5,000 | 293,600 | 12,192 | |
| Jun 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 170.04 | 5,000 | 850,212 | 36,268 | 41.3 K to 36.3 K (-12.12 %) |
| Jun 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Buy | M | 58.72 | 5,000 | 293,600 | 41,268 | 36.3 K to 41.3 K (+13.79 %) |
| May 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 164.64 | 1,420 | 233,789 | 36,203 | 37.6 K to 36.2 K (-3.77 %) |
| May 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 166.00 | 842 | 139,772 | 37,623 | 38.5 K to 37.6 K (-2.19 %) |
| May 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 164.64 | 1,420 | 233,789 | 36,203 | 37.6 K to 36.2 K (-3.77 %) |
| May 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 166.00 | 842 | 139,772 | 37,623 | 38.5 K to 37.6 K (-2.19 %) |
| Apr 18 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 156.01 | 700 | 109,207 | 38,465 | 39.2 K to 38.5 K (-1.79 %) |
| Mar 19 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 151.22 | 700 | 105,854 | 39,165 | 39.9 K to 39.2 K (-1.76 %) |
| Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 140.67 | 22,790 | 3,205,869 | 22,790 | |
| Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 140.67 | 710 | 99,876 | 710 | |
| Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 9,400 | 0 | 42,365 | 33 K to 42.4 K (+28.52 %) |
| Jan 18 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 152.16 | 700 | 106,512 | 38,959 | 39.7 K to 39 K (-1.77 %) |
| Nov 17 2017 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Sell | S | 79.90 | 5,115 | 408,689 | 0 | 5.1 K to 0 (-100.00 %) |
| Nov 17 2017 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Gift | G | 0.00 | 5,115 | 0 | 5,115 | 0 to 5.1 K |
| Nov 17 2017 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Gift | G | 0.00 | 5,115 | 0 | 2,810 | 7.9 K to 2.8 K (-64.54 %) |
| Jul 14 2017 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Grant | A | 0.00 | 1,318 | 0 | 7,925 | 6.6 K to 7.9 K (+19.95 %) |
| Jun 22 2017 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 13.78 | 14,000 | 192,920 | 14,000 | |
| May 16 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 153.79 | 815 | 125,339 | 39,533 | 40.3 K to 39.5 K (-2.02 %) |
| May 05 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 158.38 | 1,565 | 247,865 | 40,348 | 41.9 K to 40.3 K (-3.73 %) |
| Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 136.18 | 24,266 | 3,304,544 | 24,266 | |
| Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 136.18 | 734 | 99,956 | 734 | |
| Mar 06 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 10,000 | 0 | 41,913 | 31.9 K to 41.9 K (+31.34 %) |
| Mar 01 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 136.97 | 1,994 | 273,118 | 31,913 | 33.9 K to 31.9 K (-5.88 %) |
| Jun 20 2016 | PRAH | PRA Health Science ... | Young Matthew P. | Director | Grant | A | 0.00 | 2,983 | 0 | 6,607 | 3.6 K to 6.6 K (+82.31 %) |
| Jun 14 2016 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 10.17 | 14,000 | 142,380 | 14,000 | |
| May 13 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 145.23 | 815 | 118,362 | 33,809 | 34.6 K to 33.8 K (-2.35 %) |
| May 05 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 152.47 | 1,177 | 179,457 | 34,624 | 35.8 K to 34.6 K (-3.29 %) |
| Mar 02 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 121.58 | 422 | 51,307 | 35,801 | 36.2 K to 35.8 K (-1.17 %) |
| Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 123.36 | 21,689 | 2,675,555 | 21,689 | |
| Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 123.36 | 811 | 100,045 | 811 | |
| Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 125.00 | 737 | 92,125 | 36,223 | 37 K to 36.2 K (-1.99 %) |
| Feb 29 2016 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 9,000 | 0 | 36,960 | 28 K to 37 K (+32.19 %) |
| Oct 09 2015 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 12.00 | 26,985 | 323,820 | 26,985 | |
| May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 176.60 | 801 | 141,457 | 27,662 | 28.5 K to 27.7 K (-2.81 %) |
| May 06 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 183.23 | 1,127 | 206,500 | 28,463 | 29.6 K to 28.5 K (-3.81 %) |
| Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 175.19 | 19,430 | 3,403,942 | 19,430 | |
| Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 175.19 | 570 | 99,858 | 570 | |
| Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 170.09 | 437 | 74,329 | 29,590 | 30 K to 29.6 K (-1.46 %) |
| Mar 02 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 7,675 | 0 | 30,027 | 22.4 K to 30 K (+34.34 %) |
| May 14 2014 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | SVP & CFO | Option Exercise | A | 130.23 | 288 | 37,506 | 288 | |
| May 14 2014 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | SVP & CFO | Option Exercise | A | 130.23 | 12,212 | 1,590,369 | 12,212 | |
| May 14 2014 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | SVP & CFO | Grant | A | 0.00 | 6,250 | 0 | 21,880 | 15.6 K to 21.9 K (+39.99 %) |
| May 07 2014 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | SVP & CFO | Payment of Exercise | F | 141.98 | 1,127 | 160,011 | 15,630 | 16.8 K to 15.6 K (-6.73 %) |
Page: 1